Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Evaluating the Impact of CONNECT, a Novel Smoking Cessation Intervention, in a Diverse, Multilingual Population

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a video doctor with personalized responses, text message and telephone call support and connection with a pharmacist to assist in obtaining nicotine replacement medication. This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current adult smokers within the Spanish and Cantonese speaking communities.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: t
View:

• Age 50-80 years old.

• Current smokers defined at smoking at least one cigarette in past 7 days AND eligible for lung cancer screening (LCS) based on smoking history (\>=20 pack year history)

• California (CA) residents

• Able to understand and comply with study procedures for the entire length of the study.

• Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.

Locations
United States
California
University of California San Francisco
RECRUITING
San Francisco
Contact Information
Primary
Anita Ponce, MSc
Anita.Ponce@ucsf.edu
415-502-1317
Time Frame
Start Date: 2025-08-07
Estimated Completion Date: 2028-03-31
Participants
Target number of participants: 439
Treatments
Other: Focus Group
Participants in the focus group will be interviewed by the study staff and discuss barriers and facilitators to smoking cessation to be implemented in the beta and randomized phases of the study.
Active_comparator: Beta Group
Participants will be testing the CONNECT multilingual smoking cessation materials and provide feedback to investigators. Participation will be limited to about 1.5 - 2 hours.
Experimental: Group 1: CONNECT Multi-lingual intervention
Participants receive the CONNECT multilingual smoking cessation intervention finalized in the beta group analysis, that includes multi-lingual interactive video doctor intervention, text messages once weekly for 12 weeks, and several telephone counseling calls. Participants also receive access to a pharmacist to receive counseling about quitting smoking and may prescribe nicotine replacement therapy. Participants will be asked to provide a saliva sample at the end of the study
Experimental: Group 2: Control Group
Participants will receive usual care for smoking cessation at routine medical visit and be asked to complete a total of four brief follow-up phone surveys. Participants will be asked to provide a saliva sample at the end of the study.
Related Therapeutic Areas
Sponsors
Collaborators: Tobacco Related Disease Research Program
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov